May 18, 2026
Thank you for all your efforts on this study so far!
Initiation expected in Nov-2026 for those who have participants starting to enroll early Jan-2027 (more details forthcoming)
52 weeks of treatment, eligible to roll over at participant's Week 78 visit on 301/302
Participants who had previously received placebo on 301/302 will be randomized to 7.5mg, 12.5mg or 17.5mg
As we head into the warmer summer months across most of the US, please ensure you are reminding participants of the importance of adequate hydration. Staying properly hydrated by drinking enough water every day is important for overall health and supporting weight loss.
Participants may need to increase their water intake in hot or humid weather, if they are exercising or working out, or if they experience any vomiting, diarrhea or other fluid loss. Please continue to ask and remind them about water intake and good hydration throughout the study.
Please provide email response to MRL data queries as soon as possible after receipt. If you have questions regarding the query, please clarify with the MRL staff copied on the query email.
.png)
